Safety and efficacy of sofosbuvir + GS5816 for 12 Weeks In Treatment Naive Patients with Hepatitis C Virus Genotype 1-6 Infection.
Phase of Trial: Phase II
Latest Information Update: 14 May 2014
Price : $35 *
At a glance
- Drugs Sofosbuvir (Primary) ; Velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 May 2014 New trial record
- 13 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.